WO2015188053A1 - Mechanochemical platform and sensing methods using dna origami nanostructures - Google Patents

Mechanochemical platform and sensing methods using dna origami nanostructures Download PDF

Info

Publication number
WO2015188053A1
WO2015188053A1 PCT/US2015/034396 US2015034396W WO2015188053A1 WO 2015188053 A1 WO2015188053 A1 WO 2015188053A1 US 2015034396 W US2015034396 W US 2015034396W WO 2015188053 A1 WO2015188053 A1 WO 2015188053A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
set forth
tiles
biosensing
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2015/034396
Other languages
French (fr)
Inventor
Hanbin Mao
Deepak P. KOIRALA
Hiroshi Sugiyama
Masayuki Endo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyoto University NUC
Kent State University
Original Assignee
Kyoto University NUC
Kent State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto University NUC, Kent State University filed Critical Kyoto University NUC
Priority to US15/315,856 priority Critical patent/US10690685B2/en
Publication of WO2015188053A1 publication Critical patent/WO2015188053A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6825Nucleic acid detection involving sensors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00Manufacture or treatment of nanostructures
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/49Platelet-derived growth factor [PDGF]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/70Nanostructure
    • Y10S977/832Nanostructure having specified property, e.g. lattice-constant, thermal expansion coefficient
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/84Manufacture, treatment, or detection of nanostructure
    • Y10S977/88Manufacture, treatment, or detection of nanostructure with arrangement, process, or apparatus for testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/902Specified use of nanostructure
    • Y10S977/904Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/924Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis

Definitions

  • the invention relates generally to a biosensing platform and mechanism which is capable of high throughput mechanochemical biosensing which uses a DNA origami nanostructure having a plurality of slots into which recognition elements are placed so as to facilitate the detection of an event such as a conformational change in the origami nanostructure, and the apparatus that senses the change.
  • DNA origami approach has been exploited to fabricate a wide range of 2D and 3D DNA nanostructures.
  • Such nanostructures have been extensively used in many applications including nanorobotics, molecular computation, and drug delivery.
  • biosensing applications of the DNA origami structures have not been explored well.
  • DNA origami nanostructures provide a biocompatible environment, suitable for many biological reactions.
  • chemical components of the origami-based DNA nanostructures are precisely known and can be well controlled at any location, which allow a facile modification and ready incorporation of functional components in the 2D or 3D nanoassembly.
  • the present inventors have previously developed a first-in-class biosensing mechanism that employs mechanochemistry principles to detect single-nucleotide polymorphism in DNA sequences.
  • Mechanochemistry is an emerging discipline that deals with the coupling of mechanical and chemical processes. Under mechanical stress, the stability of covalent or non- covalent bonds changes, which either strengthens or weakens molecular structures. In mechanochemical sensing, the binding affinity between a receptor-ligand complex changes mechanical tension of either a free receptor or substrate. To serve as an effective mechanochemical sensor, therefore, the signal transduction unit must exploit mechanical signals, such as mechanical work, tension in a recognition template, or pressure in a system.
  • the mechanochemical sensor Since the force signal experiences little environmental interference, the mechanochemical sensor has an advantage of high signal-to-noise ratio.
  • the mechanochemical coupling employed in this type of sensor gives rise to a change in the mechanical property of a template as it recognizes a target through chemical interactions. Therefore, target recognition and signal transduction units in a traditional sensor can be integrated. This not only simplifies the sensing scheme, but also improves the performance of the sensor, since noise present in extra components of a sensing scheme can be avoided.
  • optical tweezers are an ideal tool used for mechanochemical sensing.
  • the throughput of the sensing is low since each time only one template can be investigated.
  • a problem of the invention was to develop high throughput mechanochemical sensing platforms and sensing methods.
  • a solution to the problem is provided as the inventors have designed and synthesized a DNA origami template to develop high-throughput mechanochemical biosensing in optical tweezers.
  • the origami nanostructure contains multiple slots into which many recognition elements, such as aptamers or DNA strands, can be placed strategically. This modular strategy allows quick and facile switch of different probes without redesigning the whole nanoassembly from scratch.
  • the invention in a first embodiment, relates to a biosensing platform comprising a multi- tile, e.g. a 7-tile sensing DNA origami nanostructure 10, in which multiple sensing units in the form of recognition elements are placed as the interlocks that connect the adjacent tiles.
  • the binding of a target to any of the recognition element breaks the lock, which generates a change in mechanical signal.
  • the first recognition element was PDGF aptamer which was used as the recognition element in each of the 6 linking elements or "interlocks", labeled 1-6 in FIG. la.
  • the invention leads to the detection of 10 pM PDGF within 10 minutes with a detection mode that used a ramping force or a constant force.
  • the origami sensing of the present invention provides a new paradigm, expanding the limits of self-assembled DNA nanostructures for their applications in the mechanochemical sensing, along with their well- known roles in nanotechnology, drug delivery, and molecular robotics.
  • Figure 1 provides a.) a schematic representation of the experimental set-up for a 7-tile 2D DNA origami nanoassembly tethered between two optically trapped beads through dsDNA handles modified with a terminal digoxigenin or biotin.
  • This figure also includes b.) an AFM image of 7-tile DNA origami nanostructure and c.) illustrates how binding of a target to an aptamer breaks a lock between two adjacent origami tiles;
  • Figure 2 demonstrates the specific features, mechanochemical properties, of 7-tile DNA origami nanoassembly, illustrating a.) a portion of a typical force-extension curve for the 7-tile nanoassembly, in which the aptamer lock is constituted by a PDGF aptamer and its complementary DNA strand.
  • the force-induced unlocking events are depicted by the arrowheads, b.) the change in extension due to the unlocking or tile disintegration events at a particular force.
  • the ellipses represent 95% confidence interval for each population; c.) histogram of the change in extension for all individual cooperative events; d.) histogram of the cumulative change in extension of all events observed in a single 7-tile nanostructure; e.) probability of unlocking in each nanoassembly shows that 4 unlocking events are most probable; f.) the probability of co-operative unlocking events suggests that one -by-one, rather than simulanteous, unlocking is predominant;
  • Figure 3 illustrates the characteristics of 7-tiles DNA origami nanoassembly in the presence of PDGF target.
  • the figure shows a.) representative force-extension curves of the 7-tile DNA nanoassembly in the absence and presence of 50 nM PDGF.
  • this ramping force detection mode the force-induced unlocking events were absent in the solution containing the PDGF;
  • b. comparision of the unlocking events observed per molecule in the absence and presence of the PDGF.
  • the black bars are slightly offset for clarity;
  • the binding of the target unlocked the tiles, leading to the extension jumps; d.) the probability of detecting at least one unlocking event within 10 minutes as a fuction of the PDGF concentration. Notice that below 0.1 nM the constant force detection was used while ramping force detection was used for higher concentrations;
  • Figure 4 represents the design of DNA origami construct and the corresponding sensing scheme used in the present invention showing PDGF and Target DNA recognition elements in the same DNA origami nanostructure, specifically illustrating multiplex sensing of the PDGF and Target DNA in a 7-tile DNA origami platform
  • a. is a schematic of the DNA construct showing PDGF and Target DNA recognition scheme.
  • the lock between Tiles A and B contains the PDGF recognition element whereas the lock between tile B and tile E contains a DNA sensing element.
  • Figure 5 describes a sensing platform that illustrates simultaneous detection of multiple targets using a 3D DNA origami nanoassembly.
  • the figure includes a.) a schematic of the sending platform.
  • the lock between tiles A and B contains a PDGF aptamer sequence whereas that between the tiles B and E consists of a toehold DNA strand. All other tiles remain unlocked; b.) an AFM inage of the construct showing the connection between the tiles B and E. Note that this assembly had no aptamer lock between tiles A and B; c.) typical force-extension curves and d.) corresponding AL histograms in target free solution, 5 ⁇ target DNA (middle panel), and 50 nM PDGF (lower panel).
  • FIG. 1 A 7-tile 2D DNA origami nanoassembly shown at 10 is tethered between two optically trapped beads 12 through dsDNA handles 14 modified with a terminal digoxigenin or biotin.
  • Each tile 16 of the origami nanostructure has a dimension of 39.5 x 27 nm . The adjacent tiles are locked by an aptamer DNA 18 (and its complementary strand 20.
  • Figure lb. is an AFM image (400 x 300 nm ) of the origami nanoassembly depicting 7-tiles and two dsDNA handles.
  • Figure lc. is an Illustration of the tile-unlocking due to the target binding to an aptamer lock. Binding of a target, (i.e., the thing being examined such as DNA, RNA or protein), to the aptamer induces the folding of the aptamer, which releases the complementary strand and dissembles the lock. The change in force or bead-to-bead distance due to target induced unlocking of the tiles can be monitored in real time by laser tweezers.
  • the present inventors designed and synthesized a 2D DNA origami comprising of seven interlocked tiles by using a linear M13mpl8 DNA scaffold ( Figure la. and b.). Each tile has a dimension of 39.5 x 27 nm . Two adjacent tiles are locked by using complementary DNA strands. One DNA strand contains an aptamer based target recognition element that can change its conformation upon binding with a specific target, thereby unlocking the tiles ( Figure lc).
  • the terminal tiles of the DNA origami to the two optically trapped beads through dsDNA handles, the target binding and the unlocking events in the mechanochemical platform are monitored by optical tweezers ( Figure la.).
  • Figure 2a shows the mechanochemical properties of the 7-tile nanoassembly, and, in particular, a portion of a typical force -extension curve for the 7-tile nanoassembly in which the aptamer lock is constituted by a PDGF aptamer and its complementary DNA strand.
  • the force- induced unlocking events are depicted by the arrowheads.
  • Figure 2b. shows the change in extension due to the unlocking 25 or tile disintegration 27 events at a particular force.
  • the ellipses represent 95% confidence interval for each population.
  • Figure 2c. is a histogram of the change in extension for all individual cooperative events.
  • Figure 2d is a histogram of the change in extension for all individual cooperative events.
  • Figure 3 illustrates mechanochemical sensing of PDGF using 7-tile nanoassembly in optical tweezers.
  • Figure 3a shows representative force-extension curves of the 7-tile DNA nanoassembly in the absence 30 and presence 32 of 50 nM PDGF. In this ramping force detection mode, the force-induced unlocking events (arrowheads) were absent in the solution containing the PDGF.
  • Figure 3b shows a comparison of the unlocking events observed per molecule in the absence and presence of the PDGF. The first sets of bars are slightly offset for clarity.
  • Figure 3c. is a real time observation of the target recognition events in the constant force (8 pN) detection mode. Without PDGF, no recognition events (arrowheads) were observed.
  • Figure 3d illustrates the probability of detecting at least one unlocking event within 10 minutes as a function of the PDGF concentration. Below 0.1 nM the constant force detection was used, while ramping force detection was used for higher concentrations.
  • the inventors placed the aptamer lock between tiles A and B and the toehold lock comprising of Oligo-B and Oligo-E between tiles B and E ( Figure 4a.) All other tiles were left unconnected to reduce the complexity of the system.
  • Such a design allows extension jumps of ⁇ 15 and ⁇ 40 nm for the recognition of PDGF by the aptamer lock and Target DNA by the toehold lock, respectively ( Figures 4b. and a).
  • Shown in the Figure 5b. is an AFM image of a typical 7-tile DNA origami in which connection between the tiles B and E are clearly shown, in which the Oligo-B and its partially complementary strand (Oligo-E) were used as a lock. In the presence of the Target DNA, the tiles were disintegrated due to the target DNA binding to the lock.
  • Figure 4a.-c. illustrates multiplex sensing of the PDGF and Target DNA in a 7-tile DNA origami platform.
  • Figure 4a. is a schematic of the DNA construct showing PDGF and Target DNA recognition scheme. The lock 40 between tiles A and B contains the PDGF recognition element whereas the lock 42 between tile B and tile E contains a DNA sensing element. All other tiles were remained unlocked.
  • Figure 4b. shows binding of the PDGF ligand which unlocks the tiles A and B causing ⁇ 15 nm change in extension.
  • Figure 4c. shows the binding of the Target DNA through a toehold strand displacement mechanism which unlocks tiles B, C, D and E, causing ⁇ 40 nm change in extension. Because of the twisted geometry of the C and D tiles in the middle, the predicted change in extension would be similar to that of simultaneous disassembly of the locks between B-C, C-D and D-E tiles.
  • Figure 5a.-e. illustrates simultaneous detection of multiple targets 50 using the 7-tile origami nanoassembly 10.
  • Figure 5 a. represents a schematic of the sensing platform 55.
  • the lock 57 between tiles A and B contains a PDGF aptamer sequence whereas the lock 59 between the tiles B and E consists of a toehold DNA strand. All other tiles remained unlocked.
  • Figure 5b. is an AFM image of the construct showing the connection (black arrow) between the tiles B and E. This assembly had aptamer lock between tiles A and B.
  • Figure 5c. shows typical force-extension curves and Figure 5d.
  • FIG. 5e shows real time detection of multiple targets in the constant force mode (8 pN) at low concentrations (25 nM and 5 ⁇ for PDGF and target DNA, respectively).
  • the sensor showed no extension-jumps. When both targets were present, two extension-jumps consistent with the breaking of the two locks were observed (left panel). In the solution that contains only one target, one extension jump was observed (right panel).
  • the inventors set out to perform multiplex mechanochemical sensing using ramping-force and constant- force detection modes in optical tweezers.
  • the F-X curve showed two features in the target free buffer: one has ⁇ of ⁇ 40 nm and other with ⁇ 15 nm ( Figure 5c. and d., top panel). These two values are consistent with the predicted values for the unlocking of the A-B and B-E tiles, respectively.
  • the presence of 50 nM PDGF and 5 ⁇ target DNA such features were absent, suggesting that the binding of the targets to their respective sites prior to the mechanical unfolding experiments.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)

Abstract

A biosensing platform capable of high throughput mechanochemical biosensing comprising a DNA origami nanostructure having a plurality of slots into which recognition elements are strategically placed and apparatus that senses a change in the origami nanostructure in response to the introduction of a target where the apparatus includes a signal transduction unit and signal sensor which exploits mechanical signals in a recognition element which signal includes one or more mechanical tension or mechanochemical rearrangement event. The nanostructure is preferably a 2-dimensional or 3-dimensional arrangement of tiles linked by locking elements, such as aptamers that will open in response to an event such as exposure to a drug molecule, DNA, RNA or protein target.

Description

MECHANOCHEMICAL PLATFORM AND SENSING METHODS
USING DNA ORIGAMI NANOSTRUCTURES
FIELD OF THE INVENTION
[0001] The invention relates generally to a biosensing platform and mechanism which is capable of high throughput mechanochemical biosensing which uses a DNA origami nanostructure having a plurality of slots into which recognition elements are placed so as to facilitate the detection of an event such as a conformational change in the origami nanostructure, and the apparatus that senses the change.
BACKGROUND OF THE INVENTION
[0002] After its discovery in 2006, DNA origami approach has been exploited to fabricate a wide range of 2D and 3D DNA nanostructures. Such nanostructures have been extensively used in many applications including nanorobotics, molecular computation, and drug delivery. However, the biosensing applications of the DNA origami structures have not been explored well. Compared to conventional carbon or metal based substrates for nanoassembly, DNA origami nanostructures provide a biocompatible environment, suitable for many biological reactions. In addition, the chemical components of the origami-based DNA nanostructures are precisely known and can be well controlled at any location, which allow a facile modification and ready incorporation of functional components in the 2D or 3D nanoassembly. These properties render DNA origami an outstanding platform for high throughput and multiplex biosensing.
[0003] The present inventors have previously developed a first-in-class biosensing mechanism that employs mechanochemistry principles to detect single-nucleotide polymorphism in DNA sequences. Mechanochemistry is an emerging discipline that deals with the coupling of mechanical and chemical processes. Under mechanical stress, the stability of covalent or non- covalent bonds changes, which either strengthens or weakens molecular structures. In mechanochemical sensing, the binding affinity between a receptor-ligand complex changes mechanical tension of either a free receptor or substrate. To serve as an effective mechanochemical sensor, therefore, the signal transduction unit must exploit mechanical signals, such as mechanical work, tension in a recognition template, or pressure in a system. Since the force signal experiences little environmental interference, the mechanochemical sensor has an advantage of high signal-to-noise ratio. The mechanochemical coupling employed in this type of sensor gives rise to a change in the mechanical property of a template as it recognizes a target through chemical interactions. Therefore, target recognition and signal transduction units in a traditional sensor can be integrated. This not only simplifies the sensing scheme, but also improves the performance of the sensor, since noise present in extra components of a sensing scheme can be avoided.
[0004] Due to the superior property of force and spatial resolutions, optical tweezers are an ideal tool used for mechanochemical sensing. However, the throughput of the sensing is low since each time only one template can be investigated. Thus, a problem of the invention was to develop high throughput mechanochemical sensing platforms and sensing methods.
SUMMARY OF THE INVENTION
[0005] In accordance with the present invention, a solution to the problem is provided as the inventors have designed and synthesized a DNA origami template to develop high-throughput mechanochemical biosensing in optical tweezers. The origami nanostructure contains multiple slots into which many recognition elements, such as aptamers or DNA strands, can be placed strategically. This modular strategy allows quick and facile switch of different probes without redesigning the whole nanoassembly from scratch.
[0006] In a first embodiment, the invention relates to a biosensing platform comprising a multi- tile, e.g. a 7-tile sensing DNA origami nanostructure 10, in which multiple sensing units in the form of recognition elements are placed as the interlocks that connect the adjacent tiles. The binding of a target to any of the recognition element breaks the lock, which generates a change in mechanical signal. The first recognition element was PDGF aptamer which was used as the recognition element in each of the 6 linking elements or "interlocks", labeled 1-6 in FIG. la. The invention leads to the detection of 10 pM PDGF within 10 minutes with a detection mode that used a ramping force or a constant force. This represents a significant improvement as 100 pM of a target was previously observed within 30 minutes in the prior art mechanochemical sensing that uses only one sensing unit to demonstrate the capability for sensing of single nucleotide polymorphism. In a further embodiment of the present invention, a simple rewiring of the "interlocks" or staples in the origami design leads to a 3D arrangement of the 7-tile template. This allows the observance of the binding of PDGF and the complementary DNA strand in the same origami. The 3D in tile design also helped with the identification of individual targets by different size change during mechanochemical detection. Thus, the origami sensing of the present invention provides a new paradigm, expanding the limits of self-assembled DNA nanostructures for their applications in the mechanochemical sensing, along with their well- known roles in nanotechnology, drug delivery, and molecular robotics.
BRIEF DESCRIPTION OF THE DRAWINGS
[0007] The invention will be better understood and other features and advantages will become apparent by reading the detailed description of the invention, taken together with the drawings, wherein:
[0008] Figure 1 provides a.) a schematic representation of the experimental set-up for a 7-tile 2D DNA origami nanoassembly tethered between two optically trapped beads through dsDNA handles modified with a terminal digoxigenin or biotin. This figure also includes b.) an AFM image of 7-tile DNA origami nanostructure and c.) illustrates how binding of a target to an aptamer breaks a lock between two adjacent origami tiles;
[0009] Figure 2 demonstrates the specific features, mechanochemical properties, of 7-tile DNA origami nanoassembly, illustrating a.) a portion of a typical force-extension curve for the 7-tile nanoassembly, in which the aptamer lock is constituted by a PDGF aptamer and its complementary DNA strand. The force-induced unlocking events are depicted by the arrowheads, b.) the change in extension due to the unlocking or tile disintegration events at a particular force. The ellipses represent 95% confidence interval for each population; c.) histogram of the change in extension for all individual cooperative events; d.) histogram of the cumulative change in extension of all events observed in a single 7-tile nanostructure; e.) probability of unlocking in each nanoassembly shows that 4 unlocking events are most probable; f.) the probability of co-operative unlocking events suggests that one -by-one, rather than simulanteous, unlocking is predominant;
[0010] Figure 3 illustrates the characteristics of 7-tiles DNA origami nanoassembly in the presence of PDGF target. The figure shows a.) representative force-extension curves of the 7-tile DNA nanoassembly in the absence and presence of 50 nM PDGF. In this ramping force detection mode, the force-induced unlocking events were absent in the solution containing the PDGF; b.) comparision of the unlocking events observed per molecule in the absence and presence of the PDGF. The black bars are slightly offset for clarity; c.) real time observation of the target recognition events in the constant force (8 pN) detection mode. Without PDGF, no recognition events were observed. Upon switching to the target solution (24 nM PDGF), the binding of the target unlocked the tiles, leading to the extension jumps; d.) the probability of detecting at least one unlocking event within 10 minutes as a fuction of the PDGF concentration. Notice that below 0.1 nM the constant force detection was used while ramping force detection was used for higher concentrations;
[0011] Figure 4 represents the design of DNA origami construct and the corresponding sensing scheme used in the present invention showing PDGF and Target DNA recognition elements in the same DNA origami nanostructure, specifically illustrating multiplex sensing of the PDGF and Target DNA in a 7-tile DNA origami platform wherein, a.) is a schematic of the DNA construct showing PDGF and Target DNA recognition scheme. The lock between Tiles A and B contains the PDGF recognition element whereas the lock between tile B and tile E contains a DNA sensing element. All other tiles remained unlocked; b.) binding of the PDGF ligand unlocks the tiles A and B causing ~15 nm change in extension; c.) the binding of the Target DNA through a toehold strand displacement mechanism unlocks tiles B, C, D and E, causing ~40 nm change in extension. Because of the twisted geometry of the C and D tiles in the middle, the predicted change in extension would be similar to that of simultaneous disassembly of the locks between B-C, C-D and D-E tiles; and
[0012] Figure 5 describes a sensing platform that illustrates simultaneous detection of multiple targets using a 3D DNA origami nanoassembly. The figure includes a.) a schematic of the sending platform. The lock between tiles A and B contains a PDGF aptamer sequence whereas that between the tiles B and E consists of a toehold DNA strand. All other tiles remain unlocked; b.) an AFM inage of the construct showing the connection between the tiles B and E. Note that this assembly had no aptamer lock between tiles A and B; c.) typical force-extension curves and d.) corresponding AL histograms in target free solution, 5 μιη target DNA (middle panel), and 50 nM PDGF (lower panel). In target free solution, two force-induced unlocking events were observed. In the presence of one target, one unlocking even was observed. In the ramping-force detection mode, unlocking events were not observed in the presence of both targets (50 nM PDGF and 5 μΜ target DNA); e.) real time detection of multiple targets in the constant force mode (8 pN) at low concentrations (25 nM and 5 μΜ for PDGF and target DNA, respectively). In target free solution, the sensor showed no extension-jumps. When both targets were present, two extension-jumps consistent with the breaking of the two locks were observed (left panel). In the solution that contains only one target, one extension jump was observed (right panel).
DETAILED DESCRIPTION OF THE INVENTION
[0013] To prepare a DNA origami structure, a long single-stranded DNA scaffold can be folded into a predesigned 2D or 3D DNA nanostructure aided by short DNA staples. Figure la.-c. illustrates the Experimental set-up for a DNA origami based mechanochemical sensing using optical tweezers (not to scale). A 7-tile 2D DNA origami nanoassembly shown at 10 is tethered between two optically trapped beads 12 through dsDNA handles 14 modified with a terminal digoxigenin or biotin. Each tile 16 of the origami nanostructure has a dimension of 39.5 x 27 nm . The adjacent tiles are locked by an aptamer DNA 18 (and its complementary strand 20. Figure lb. is an AFM image (400 x 300 nm ) of the origami nanoassembly depicting 7-tiles and two dsDNA handles. Figure lc. is an Illustration of the tile-unlocking due to the target binding to an aptamer lock. Binding of a target, (i.e., the thing being examined such as DNA, RNA or protein), to the aptamer induces the folding of the aptamer, which releases the complementary strand and dissembles the lock. The change in force or bead-to-bead distance due to target induced unlocking of the tiles can be monitored in real time by laser tweezers.
[0014] Using this strategy, the present inventors designed and synthesized a 2D DNA origami comprising of seven interlocked tiles by using a linear M13mpl8 DNA scaffold (Figure la. and b.). Each tile has a dimension of 39.5 x 27 nm . Two adjacent tiles are locked by using complementary DNA strands. One DNA strand contains an aptamer based target recognition element that can change its conformation upon binding with a specific target, thereby unlocking the tiles (Figure lc). By attaching the terminal tiles of the DNA origami to the two optically trapped beads through dsDNA handles, the target binding and the unlocking events in the mechanochemical platform are monitored by optical tweezers (Figure la.).
[0015] Figure 2a. shows the mechanochemical properties of the 7-tile nanoassembly, and, in particular, a portion of a typical force -extension curve for the 7-tile nanoassembly in which the aptamer lock is constituted by a PDGF aptamer and its complementary DNA strand. The force- induced unlocking events are depicted by the arrowheads. Figure 2b. shows the change in extension due to the unlocking 25 or tile disintegration 27 events at a particular force. The ellipses represent 95% confidence interval for each population. Figure 2c. is a histogram of the change in extension for all individual cooperative events. Figure 2d. is a histogram of the cumulative change in extension of all events observed in a single 7-tile nanostructure. Figure 2e. shows probability of unlocking each nanoassembly shows that 4 unlocking events are most probable. Figure 2f. illustrates the probability of co-operative unlocking events suggests that one- by-one, rather than simultaneous, unlocking is predominant.
[0016] Before sensing applications, the present inventors characterized the mechanical properties of this DNA origami structure. Previously, origami has served as tethering handles for mechanical unfolding experiments. However, the mechanical stability of origami has not been well investigated. Force-ramping experiments were performed to increase the tension in the origami nanostructure by moving one of the traps away from the other. This allowed the observation of two types of unfolding events in the force-extension curves. In the force range between 10-25 pN (Figure 2a.), the inventors observed < 6 events with a change-in-extension (Δχ) of ~15 nm for each transition. This is consistent with the disassembly of the aptamer lock (Figure2b., population PI). However, in the range above 30 pN, the inventors observed saw-teeth features with Δχ of -100 nm (Figure 2b., population P2). In a control construct without any interlocks between adjacent tiles, only > 30 pN events were observed, confirming that the features between 10-25 pN are associated with the opening of the aptamer interlocks. Such an observation was further validated by performing experiments in which interlocks with shorter dsDNA were used. In these experiments, the unlocking forces (< 30 pN) were reduced, which reflects less Watson-Crick base pairing in the dsDNA lock. Based on these results, only the force range between 10-25 pN (Figure 2b., population PI) was considered for the mechanochemical sensing experiments.
[0017] The histogram of the change-in-extension (Δχ) for all individual features of population PI shows a dominant peak at ~15 nm with a shoulder at ~25 nm (Figure 2c). However, features with longer (Δχ) were rare, suggesting unlocking events were non-cooperative. The histogram for the cumulative (Δχ) (Figure 2d.) demonstrated six peaks with Gaussian centers of 14 ± 0.5, 33 ± 1.0, 50 ± 2.5, 70 ± 2, 90 ± 4, and 123 ± 4 nm, which were consistent with the predicted Δχ patterns. The maximum probability of the peak at 70 nm indicates that four tiles, instead of six, are most probable to be locked. This was confirmed by the probability of the unlocked events per molecule based on the observed Δχ (Figure 2e.). The fact that 4 instead of 6 locks were most likely observed reflects the efficiency in the DNA origami preparation in which 100% assembly was rarely observed. The one -by-one, rather than simultaneous, unlocking of the tiles was confirmed in Figure 2f. in which the most likely transition was associated with a single unlocking event during each unfolding.
[0018] Figure 3 illustrates mechanochemical sensing of PDGF using 7-tile nanoassembly in optical tweezers. Figure 3a. shows representative force-extension curves of the 7-tile DNA nanoassembly in the absence 30 and presence 32 of 50 nM PDGF. In this ramping force detection mode, the force-induced unlocking events (arrowheads) were absent in the solution containing the PDGF. Figure 3b. shows a comparison of the unlocking events observed per molecule in the absence and presence of the PDGF. The first sets of bars are slightly offset for clarity. Figure 3c. is a real time observation of the target recognition events in the constant force (8 pN) detection mode. Without PDGF, no recognition events (arrowheads) were observed. Upon switching to the target solution (25 nM PDGF), the binding of the target unlocked the tiles, leading to the extension jumps (arrowheads). Figure 3d. illustrates the probability of detecting at least one unlocking event within 10 minutes as a function of the PDGF concentration. Below 0.1 nM the constant force detection was used, while ramping force detection was used for higher concentrations.
[0019] After characterization of the 7-tile origami nanostructure, the inventors employed this platform to detect the PDGF target. Binding of the PDGF to the aptamer strand in each lock helps to fold and stabilize the secondary structure of the aptamer, which leads to the disassembly of the origami tiles. Indeed, in the presence of 50 nM PDGF, unfolding of origami tiles was not observed as locks had been disintegrated by binding of PDGF prior to the pulling experiments (Figure 3 a.). Analysis of the unlocking events per molecule confirmed this observation. Whereas a maximum of 4 unlocking events per molecule were observed without PDGF, zero unlocking was the most frequent observation with 50 nM PDGF (Figure 3b.). To detect the binding of PDGF in real time, the inventors switched the detection to the constant force mode, in which the tension in the tethered molecule was maintained at 8 pN while the extension was monitored. As expected, the tension remained constant in a PDGF free solution over time (Figure 3c). With 25 nM PDGF, however, many extension-jumps were observed (Figure 3c). The size of each jump was consistent with expected values when neighboring tiles are separated. In addition, the patterns of the number of jumps were similar to that observed in force ramp mode in Figure 2e. (data not shown). Using the ramping-force and constant-force detection modes for high (>25 nM) and low (<0.1 nM) concentrations of the PDGF, respectively, the inventors performed similar experiments for a series of PDGF concentrations. Figure 3d. shows the probability of observing at least one unlocking event within 10 minutes. From this diagram, the inventors estimated a detection limit of 10 pM (3σ) within 10 minutes. Compared to the detection limit of 100 pM in 30 minutes in a mechanochemical sensor that contains only one recognition element, the results described here provide a strong support that the multiple recognition probes can effectively improve the detection by lowering the detection limit while significantly reducing the detection time.
[0020] Next, to demonstrate multiplexing capability of our mechanochemical sensing platform, the inventors designed a DNA origami construct comprising of multiple recognition elements (Figure 4a.). As a proof-of-concept, the inventors incorporated two different probes in the two locks separately. One lock contains the same PDGF aptamer used above while the other consists of a DNA sequence (Oligo-B) to recognize its complementary DNA strand (Target DNA). Oligo-B contains a toehold segment to preferentially bind to the Target DNA over its partially complementary strand (Oligo-E) constituting a lock. To effectively differentiate the binding of each target, the inventors placed the aptamer lock between tiles A and B and the toehold lock comprising of Oligo-B and Oligo-E between tiles B and E (Figure 4a.) All other tiles were left unconnected to reduce the complexity of the system. Such a design allows extension jumps of ~15 and ~40 nm for the recognition of PDGF by the aptamer lock and Target DNA by the toehold lock, respectively (Figures 4b. and a). Shown in the Figure 5b. is an AFM image of a typical 7-tile DNA origami in which connection between the tiles B and E are clearly shown, in which the Oligo-B and its partially complementary strand (Oligo-E) were used as a lock. In the presence of the Target DNA, the tiles were disintegrated due to the target DNA binding to the lock.
[0021] Figure 4a.-c. illustrates multiplex sensing of the PDGF and Target DNA in a 7-tile DNA origami platform. Figure 4a. is a schematic of the DNA construct showing PDGF and Target DNA recognition scheme. The lock 40 between tiles A and B contains the PDGF recognition element whereas the lock 42 between tile B and tile E contains a DNA sensing element. All other tiles were remained unlocked. Figure 4b. shows binding of the PDGF ligand which unlocks the tiles A and B causing ~15 nm change in extension. Figure 4c. shows the binding of the Target DNA through a toehold strand displacement mechanism which unlocks tiles B, C, D and E, causing ~40 nm change in extension. Because of the twisted geometry of the C and D tiles in the middle, the predicted change in extension would be similar to that of simultaneous disassembly of the locks between B-C, C-D and D-E tiles.
[0022] Figure 5a.-e. illustrates simultaneous detection of multiple targets 50 using the 7-tile origami nanoassembly 10. Figure 5 a. represents a schematic of the sensing platform 55. The lock 57 between tiles A and B contains a PDGF aptamer sequence whereas the lock 59 between the tiles B and E consists of a toehold DNA strand. All other tiles remained unlocked. Figure 5b. is an AFM image of the construct showing the connection (black arrow) between the tiles B and E. This assembly had aptamer lock between tiles A and B. Figure 5c. shows typical force-extension curves and Figure 5d. shows corresponding AL histograms in target free solution (top panel), 5 μΜ target DNA (middle panel), and 50 nM PDGF (lower panel). In target free solution, two force-induced unlocking events were observed. In the presence of one target, one unlocking event was observed. In the ramping-force detection mode, unlocking events were not observed in the presence of both targets (50 nM PDGF and 5 μΜ target DNA). Figure 5e. shows real time detection of multiple targets in the constant force mode (8 pN) at low concentrations (25 nM and 5 μΜ for PDGF and target DNA, respectively). In target free solution, the sensor showed no extension-jumps. When both targets were present, two extension-jumps consistent with the breaking of the two locks were observed (left panel). In the solution that contains only one target, one extension jump was observed (right panel).
[0023] With this design, the inventors set out to perform multiplex mechanochemical sensing using ramping-force and constant- force detection modes in optical tweezers. During the ramping-force mode, the F-X curve showed two features in the target free buffer: one has Δχ of ~40 nm and other with ~15 nm (Figure 5c. and d., top panel). These two values are consistent with the predicted values for the unlocking of the A-B and B-E tiles, respectively. In the presence of 50 nM PDGF and 5 μΜ target DNA, such features were absent, suggesting that the binding of the targets to their respective sites prior to the mechanical unfolding experiments.
[0024] To confirm these observations, the inventors performed mechanochemical sensing for the two targets separately. In the presence of the target DNA (5 μΜ) that unlocks the B-E tiles by a toehold mechanism, only the 15 nm feature was observed (Figure 5c. and d., middle panel), which corresponded to the force-induced breaking of the A-B tiles. Likewise, in the presence of the PDGF ligand that unlocks the A-B tiles, only the 40 nm feature was observed (Figure 4c. and d., bottom panel), which was associated with the unlocking of the B-E tiles. [0025] Further demonstration on the multiplex sensing came from experiments with the constant-force detection. When 8 pN was maintained in the origami template in the target free solution, breaking of the tiles was not observed (Figure 5e., left panel, upper trace). However, as soon as the sensor was taken to the solution mixture of 25 nM PDGF and 5 μΜ target DNA, two extension-jumps corresponding to the expected breaking of the two locks were observed (Figure 5e., left panel, lower trace). Such an observation was further verified when sensing was performed against individual targets in which expected extension-jump was observed for specific binding event (Figure 5e., right panel). These findings well established the capability of multiplex sensing in the DNA origami template. With the incorporation of more tiles and the full use of each tile, this mechanochemical sensing strategy is rather flexible to detect many different targets.
[0026] In summary, the principle of mechanochemical biosensing using optical tweezers was successfully demonstrated with a 7-tile DNA origami nanoassembly. The incorporation of multiple recognition sites reduces the detection limit as well as the detection time. In addition, it offers a unique and versatile approach for multiplex biosensing. The mechanical signal with little background noise warrants a superior sensitivity of the sensor at the single molecule level. With rapid development of DNA origami techniques, origami structures with increased mechanical stability and more target recognition sites are well within reach after a rational design. Therefore, the new mechanochemical sensing apparatus developed here will expand the limits of self- assembled DNA nanostructures for their potential applications in nanotechnology, drug delivery, and logic gate devices.
[0027] While in accordance with the patent statutes the best mode and preferred embodiment have been set forth, the scope of the invention is not limited thereto, but rather by the scope of the attached claims.

Claims

WHAT IS CLAIMED IS:
1. A biosensing platform which is capable of high throughput mechanochemical biosensing, comprising:
a DNA origami nanostructure having a plurality of slots into which recognition elements are strategically placed and the apparatus that senses a change in the origami nanostructure in response to the introduction of a target.
2. The biosensing platform as set forth in claim 1 , in which the apparatus that senses the change includes optical tweezers.
3. The biosensing platform as set forth in claim 1 , in which the apparatus that senses the change further comprises a signal transduction unit and signal sensor which exploits mechanical signals in a recognition element, which signal comprises one or more mechanical tension or a mechanochemical rearrangement event.
4. The biosensing platform as set forth in claim 1 , wherein the DNA origami nanostructure is either 2-dimensional or 3 -dimensional.
5. The biosensing platform as set forth in claim 4, wherein the DNA origami nanostructure is a template having multiple DNA tiles which are interlocked by the target recognition elements.
6. The biosensing platform as set forth in claim 1 , wherein the DNA origami nanostructure comprises more than 1 and less than 8 tiles which are interlocked in a 2- dimensional mode by recognition elements.
7. The biosensing platform as set forth in claim 6, in which two or more adjacent tiles of the tiles are locked with locks made up of an aptamer sequence and a complimentary DNA strand.
8. The biosensing platform as set forth in claim 3, in which at least one of the recognition elements is an aptamer based recognition element that changes its conformation upon binding with a specific target.
9. The biosensing platform as set forth in claim 8, in which the recognition elements that constitute the interlocks between the tiles are Platelet Derived Growth Factor (PDGF) aptamers.
10. The biosensing platform as set forth in claim 9, in which the PDGF aptamer recognizes a target PDGF protein and changes its conformation to unlock the tiles.
11. The biosensing platform as set forth in claim 3, in which the tiles are approximately flat rectangles, and wherein the tiles have a dimension from 20 to 50 nm by from 15 to 35 nm.
12. The biosensing platform as set forth in claim 11 , in which the DNA nanostructure has a first end and a second end and is tethered between optically trapped beads by a dsDNA handle at each of the first end and the second end of the nanostructure, wherein the dsDNA handles are attached to the first sequential tile and the last sequential tile of the DNA origami nanostructure.
13. The biosensing platform as set forth in claim 1 , in which the apparatus that senses the change senses a change in a tension or mechano chemical rearrangement of the DNA origami nanostructure, wherein the apparatus comprises optical tweezers, atomic force microscope (AFM), or other devices that can manipulate force from sub-picoNewtons to nanoNewtons.
14. The biosensing platform as set forth in claim 5, in which the recognition elements form an interlock which opens in response to exposure to a target and the opening of the interlocks occurs between 10 - 25 pN.
15. The biosensing platform as set forth in claim 14, in which there are multiple events comprising the opening of the interlocks and the opening events are non-cooperative.
16. The biosensing platform as set forth in claim 15, in which the unlocking of the tiles occurs one-by-one.
17. The biosensing platform as set forth in claim 1, a) in which DNA origami has an origami preparation the efficiency of which is at least 75%, or b) in which the DNA origami nanostructure is a 3-dimensional arrangement of tiles, or c) in which at least two different recognition elements are used in the same DNA origami nanostructure or any combination of a), b), and c).
18. The biosensing platform as set forth in claim 3, in which at least three tiles of a DNA origami nanostructure are interlocked by the recognition elements.
19. The biosensing mechanism as set forth in claim 17, in which the recognition elements include either a toe-hold DNA segment or a PDGF aptamer.
20. The biosensing mechanism as set forth in claim 19, in which toe-hold DNA fragment recognizes the target DNA sequence and the PDGF aptamer recognizes the PDGF protein and each recognition produces different mechanochemical signal.
PCT/US2015/034396 2014-06-06 2015-06-05 Mechanochemical platform and sensing methods using dna origami nanostructures Ceased WO2015188053A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/315,856 US10690685B2 (en) 2014-06-06 2015-06-05 Mechanochemical platform and sensing methods using DNA origami nanostructures

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462008529P 2014-06-06 2014-06-06
US62/008,529 2014-06-06
US201462084687P 2014-11-26 2014-11-26
US62/084,687 2014-11-26

Publications (1)

Publication Number Publication Date
WO2015188053A1 true WO2015188053A1 (en) 2015-12-10

Family

ID=54767422

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/034396 Ceased WO2015188053A1 (en) 2014-06-06 2015-06-05 Mechanochemical platform and sensing methods using dna origami nanostructures

Country Status (2)

Country Link
US (1) US10690685B2 (en)
WO (1) WO2015188053A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108187062A (en) * 2017-12-11 2018-06-22 青岛科技大学 A kind of construction method of the nano-medicament carrier based on nucleic acid
WO2022109155A1 (en) * 2020-11-18 2022-05-27 Atom Bioworks, Inc. Polynucleotide nanostructures for detecting viral infections and other diseases
WO2022207832A1 (en) * 2021-04-01 2022-10-06 Leica Microsystems Cms Gmbh Capture construct and method for detecting a plurality of analytes
CN119559634A (en) * 2024-11-22 2025-03-04 南京邮电大学 A target detection method and system for DNA nanostructures in AFM scenario

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108498451B (en) * 2018-06-19 2021-03-23 郑州轻工业学院 DNA nano-drug carrier with high drug loading effect, preparation method and application
CN109490579A (en) * 2018-12-13 2019-03-19 上海纳米技术及应用国家工程研究中心有限公司 Magnetic field is studied to the method for DNA two dimension origami structure stability influence
US11708601B2 (en) * 2019-09-06 2023-07-25 Carnegie Mellon University Micromechanical DNA origami force sensor
US20230121144A1 (en) * 2020-03-13 2023-04-20 Emory University Bionanomechanical Devices for Uses in Evaluating Liquid Dynamics
EP4259823A2 (en) * 2020-12-10 2023-10-18 Phitonex, Inc. Methods of signal amplification
EP4148130A1 (en) 2021-09-09 2023-03-15 Uniwersytet Jagiellonski Topogami and method for making interlocked single stranded dna rings
WO2023049355A1 (en) * 2021-09-23 2023-03-30 Palamedrix, Inc. Monofunctional particles
CN116355992A (en) * 2021-12-20 2023-06-30 华北电力大学 Biosensor based on DNA self-assembled nanonuclease machine and its preparation method and application
CN120847438B (en) * 2025-07-16 2026-02-03 江西众康中药饮片有限公司 Medicinal material identification system and method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7652731B2 (en) 2006-05-16 2010-01-26 Kent State University Polymer enhanced cholesteric electro-optical devices
US9796748B2 (en) * 2011-05-02 2017-10-24 President And Fellows Of Harvard College Spatial sequestration of dynamic nucleic acid circuits

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
RINKER ET AL.: "Self-assembled DNA nanostructures for distance-dependent multivalent ligand- protein binding.", NAT NANOTECHNOL, vol. 3, no. 7, July 2008 (2008-07-01), pages 418 - 422, XP002561873 *
YANGYUORU ET AL.: "Single-molecule measurements of the binding between small molecules and DNA aptamers.", ANAL CHEM, vol. 84, no. 12, 19 June 2012 (2012-06-19), pages 5298 - 5303, XP055242029 *
ZHAO ET AL.: "Organizing DNA origami tiles into larger structures using preformed scaffold frames.", NANO LETT., vol. 11, no. 7, 13 July 2011 (2011-07-13), pages 2997 - 3002, XP055242034 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108187062A (en) * 2017-12-11 2018-06-22 青岛科技大学 A kind of construction method of the nano-medicament carrier based on nucleic acid
CN108187062B (en) * 2017-12-11 2020-10-02 青岛科技大学 Construction method of nucleic acid-based nano-drug carrier
WO2022109155A1 (en) * 2020-11-18 2022-05-27 Atom Bioworks, Inc. Polynucleotide nanostructures for detecting viral infections and other diseases
WO2022207832A1 (en) * 2021-04-01 2022-10-06 Leica Microsystems Cms Gmbh Capture construct and method for detecting a plurality of analytes
CN119559634A (en) * 2024-11-22 2025-03-04 南京邮电大学 A target detection method and system for DNA nanostructures in AFM scenario

Also Published As

Publication number Publication date
US20170108517A1 (en) 2017-04-20
US10690685B2 (en) 2020-06-23

Similar Documents

Publication Publication Date Title
US10690685B2 (en) Mechanochemical platform and sensing methods using DNA origami nanostructures
Koirala et al. Single‐molecule mechanochemical sensing using DNA origami nanostructures
CN113906147B (en) Method for detecting target nucleic acid molecules
AU2011279083B2 (en) Nanopore-facilitated single molecule detection of nucleic acids
WO2006124089A1 (en) Self-assembled nucleic acid nanoarrays and uses therefor
WO2007146158A1 (en) Dna sequencing by nanopore using modified nucleotides
EP2758542B1 (en) Probe with multiple target region specificity and of tripartite character
US20080287668A1 (en) Nanostructures and methods of making
WO2012058638A9 (en) Nucleic acid nanostructure barcode probes
CN104372080A (en) Polynucleotide mapping and sequencing
JP2025514791A5 (en)
WO2016089588A1 (en) Nucleic acid-based linkers for detecting and measuring interactions
US12018317B2 (en) High throughput oil-emulsion synthesis of bowtie barcodes for paired mRNA capture and sequencing from individual cells
US20190345193A1 (en) Nucleic acid nanoswitch construction methods
WO2003066896A3 (en) Method for the detection of mutations
Feng et al. Recent advances in exosome analysis assisted by functional nucleic acid-based signal amplification technologies
Chao et al. Single-molecule imaging of DNA polymerase I (Klenow fragment) activity by atomic force microscopy
DE102017218849A1 (en) Reaction carrier for a microfluidic device and method for determining a nucleotide sequence
US10435738B2 (en) RNA microarray for detecting interaction between protein and RNA containing a higher-order structure
US20220325332A1 (en) Agile nucleic acid sensor and measuring a biomarker
CN114026251B (en) Device, system and method
US12195787B2 (en) DNA nanotechnology-based biomarker measurement platform
CN114277098B (en) Bar code system based on DNA paper folding structure
Stoop et al. Homo-DNA templated chemistry and its application to nucleic acid sensing
Yang DNA nanopore as a signal transducer for the detection of short oligonucleotides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15804000

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 15315856

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15804000

Country of ref document: EP

Kind code of ref document: A1